Amgen and AstraZeneca’s…
Amgen and AstraZeneca’s inflammatory disease drug Tezspire has clinched a [...]
Amgen and AstraZeneca’s inflammatory disease drug Tezspire has clinched a [...]
Fresh off a phase 3 win in biliary tract cancer, [...]
Baxter has initiated a recall of two products because of [...]
Bausch + Lomb has come up short in a phase [...]
The healthcare conglomerate ,which ranks eighth on the Fortune 500 [...]
Sixteen months after Johnson & Johnson scored its initial FDA [...]
With its ascent seemingly unstoppable in the last few years, [...]
Daiichi Sankyo is promoting Ken Keller to lead a new [...]
Education and insight company Community Health Media curates its content [...]
Almost three years into his tenure as Lundbeck’s CEO, Charl [...]